Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MyoKardia
Biotech
BMS' MyoKardia scraps heart muscle pact with Fulcrum
MyoKardia, a biotech BMS bought in 2020, was working with Fulcrum to find cardiomyopathy targets but recently decided to end the alliance.
Nick Paul Taylor
Mar 5, 2025 5:30am
Kardigan launches with cozy $300M, late-stage portfolio
Jan 10, 2025 1:18pm
How pythons reshape their hearts after eating massive meals
Aug 23, 2024 12:30pm
BMS, Avidity add another $100M to cardiovascular partnership
Nov 28, 2023 6:30am
$1.1B fund at Third Rock Ventures will go to 10 new biotechs
Jun 15, 2022 6:30am
Bristol Myers drug helps patients avoid heart procedures
Apr 2, 2022 9:30am
